Enliven Therapeutics: Funding, Investors & Team (Sep 2026)
Enliven Therapeutics is a company focused on precision oncology, creating small molecule treatments to extend and enhance the lives of patients with cancer. The company uses validated biological targets and advanced chemistry to overcome the shortcomings of current therapies, resulting in the development of precise and effective oncology treatments that improve patient health. Established in July 2019 by Sam Kintz, MBA, Joe Lyssikatos, PhD, and Anish Patel, PharmD, Enliven Therapeutics is located in Boulder, Colorado.
Enliven Therapeutics has raised $1.0B across 5 funding rounds on record, the most recent an undisclosed round of $460M announced in Jun 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Enliven Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Enliven Therapeutics Funding Rounds
Enliven Therapeutics raised $85.0M in a Series B announced in Jan 2022.
9 months later, an undisclosed round of $165M was announced in Oct 2022.
1.4 years later, an undisclosed round of $90.0M was announced in Mar 2024.
1.3 years later, an undisclosed round of $230M was announced in Jun 2025.
1 years later, an undisclosed round of $460M was announced in Jun 2026.
Enliven Therapeutics Founders and Leadership Team
Contact details for the Enliven Therapeutics team: 3 of 4 have an email address on file.
Start 14-day free trial →Enliven Therapeutics Funding Compared to Other Biotechnology Startups
Enliven Therapeutics' latest round of $460M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Enliven Therapeutics in Biotechnology and Boulder
Companies Similar to Enliven Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Enliven Therapeutics Funding FAQs
What does Enliven Therapeutics do?
Enliven Therapeutics is a company focused on precision oncology, creating small molecule treatments to extend and enhance the lives of patients with cancer. The company uses validated biological targets and advanced chemistry to overcome the shortcomings of current therapies, resulting in the development of precise and effective oncology treatments that improve patient health. Established in July 2019 by Sam Kintz, MBA, Joe Lyssikatos, PhD, and Anish Patel, PharmD, Enliven Therapeutics is located in Boulder, Colorado.
How much funding has Enliven Therapeutics raised?
Enliven Therapeutics has raised $1.0B across 5 rounds on record. The most recent is an undisclosed round of $460M announced in Jun 2026.
When did Enliven Therapeutics last raise funding?
Enliven Therapeutics' most recent funding round on record is an undisclosed round of $460M, announced in Jun 2026.
Who founded Enliven Therapeutics?
FundedIQ lists Anish Patel (Founder), Joe Lyssikatos (Founder), Rick Fair (Founder) at Enliven Therapeutics.
Who is the CEO of Enliven Therapeutics?
Sam Kintz is listed as CEO at Enliven Therapeutics.
Where is Enliven Therapeutics headquartered?
Enliven Therapeutics is based in Boulder, Colorado, United States.
How many employees does Enliven Therapeutics have?
Enliven Therapeutics is in the 51-100 employee band.
How does Enliven Therapeutics' funding compare to other Biotechnology startups?
Enliven Therapeutics' latest round of $460M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Enliven Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Enliven Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.